DK225287A - Pyridinderivater, fremgangsmaade til fremstilling deraf, samt farmacutiske midler indeholdende disse - Google Patents

Pyridinderivater, fremgangsmaade til fremstilling deraf, samt farmacutiske midler indeholdende disse

Info

Publication number
DK225287A
DK225287A DK225287A DK225287A DK225287A DK 225287 A DK225287 A DK 225287A DK 225287 A DK225287 A DK 225287A DK 225287 A DK225287 A DK 225287A DK 225287 A DK225287 A DK 225287A
Authority
DK
Denmark
Prior art keywords
hydrogen
pharmacutical
procedures
preparing
group
Prior art date
Application number
DK225287A
Other languages
Danish (da)
English (en)
Other versions
DK225287D0 (da
Inventor
David Gwyn Cooper
Peter Donald Miles
Rodney Christopher Young
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DK225287D0 publication Critical patent/DK225287D0/da
Publication of DK225287A publication Critical patent/DK225287A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK225287A 1986-05-02 1987-05-01 Pyridinderivater, fremgangsmaade til fremstilling deraf, samt farmacutiske midler indeholdende disse DK225287A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868610867A GB8610867D0 (en) 1986-05-02 1986-05-02 3-hydroxypyridines

Publications (2)

Publication Number Publication Date
DK225287D0 DK225287D0 (da) 1987-05-01
DK225287A true DK225287A (da) 1987-11-03

Family

ID=10597301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK225287A DK225287A (da) 1986-05-02 1987-05-01 Pyridinderivater, fremgangsmaade til fremstilling deraf, samt farmacutiske midler indeholdende disse

Country Status (10)

Country Link
US (2) US4764519A (de)
EP (1) EP0244201B1 (de)
JP (1) JPS62277359A (de)
AT (1) ATE56957T1 (de)
AU (1) AU7242587A (de)
DE (1) DE3765164D1 (de)
DK (1) DK225287A (de)
GB (1) GB8610867D0 (de)
PT (1) PT84814B (de)
ZA (1) ZA873118B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030645A (en) * 1990-10-15 1991-07-09 Merck & Co., Inc. Method of treating asthma using (S)-α-fluoromethyl-histidine and esters thereof
US5595958A (en) * 1994-05-02 1997-01-21 Zeneca Limited 3-substituted pyridine compounds and derivatives thereof
US6232316B1 (en) 1998-06-16 2001-05-15 Targacept, Inc. Methods for treatment of CNS disorders
US6455554B1 (en) * 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
JP4169958B2 (ja) * 2000-12-22 2008-10-22 積水化学工業株式会社 清拭シート
JP4084553B2 (ja) * 2000-12-22 2008-04-30 積水化学工業株式会社 アレルゲン低減化繊維
JP4084554B2 (ja) * 2000-12-22 2008-04-30 積水化学工業株式会社 アレルゲン低減化繊維
US7670707B2 (en) * 2003-07-30 2010-03-02 Altergy Systems, Inc. Electrical contacts for fuel cells
US20050095222A1 (en) * 2003-10-29 2005-05-05 Taro Suzuki Allergen inhibitor, allergen-inhibiting method, allergen-inhibiting fiber and allergen-inhibiting sheet

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4471122A (en) * 1981-03-03 1984-09-11 Bristol-Myers Company Thiadiazole histamine H2 -antagonists
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
PT77287B (en) * 1982-10-01 1986-02-04 Smith Kline French Lab Compound
JO1274B1 (en) * 1982-12-03 1985-04-20 سيدني ساخ جورج Pyridine derivatives
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
JO1279B1 (en) * 1982-12-23 1985-04-20 جون ايف روبرت Pyridine derivatives

Also Published As

Publication number Publication date
EP0244201A3 (en) 1988-10-05
EP0244201B1 (de) 1990-09-26
AU7242587A (en) 1987-11-05
JPS62277359A (ja) 1987-12-02
DE3765164D1 (en) 1990-10-31
ZA873118B (en) 1988-02-24
ATE56957T1 (de) 1990-10-15
US4764519A (en) 1988-08-16
EP0244201A2 (de) 1987-11-04
PT84814B (en) 1989-06-21
US4863933A (en) 1989-09-05
PT84814A (en) 1987-05-01
DK225287D0 (da) 1987-05-01
GB8610867D0 (en) 1986-06-11

Similar Documents

Publication Publication Date Title
DK323688D0 (da) Pyridinforbindelser
IL81483A0 (en) Piperazine derivatives and pharmaceutical compositions containing them
DK225287A (da) Pyridinderivater, fremgangsmaade til fremstilling deraf, samt farmacutiske midler indeholdende disse
DE3273782D1 (en) Pyrimidinone derivatives and pharmaceutical compositions containing them
GB1530413A (en) 5,8-dihydro-5-oxopyrido(2,3-d)pyrimidines
DK119188D0 (da) Substituerede pyridin-2,4-dicarboxylsyrederivater, fremgangsmaader til deres fremstilling samt laegemiddel indeholdende forbindelserne
DK26686A (da) Alkynderivater, fremgangsmaader til fremstilling heraf samt famaceutiske midler indeholdende disse derivater
ATE120743T1 (de) Pyridoindolderivate und verfahren zu ihrer herstellung.
ATE27818T1 (de) Pyrimidonderivate.
DK483282A (da) Heterocykliske forbindelser samt fremgangsmaade til fremstilling heraf
DK368284A (da) Aminopyrimidinonderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende aminopyrimidinonderivaterne og disses anvendelse som histamin h2-antagonister
IE852645L (en) 6-PHENYLETHYLAMINOALKYL-FURO (3,4-c) PYRIDINES
ES8601141A1 (es) Un procedimiento para la produccion de derivados de isoquinolina sustituidos
DE3782585D1 (de) 2,6-bis(chlormethyloxycarbonyloxymethyl)pyridin.
DK361083D0 (da) Fremgangsmade til fremstilling af 3-deazaguaninsulfonsyresalte samt farmaceutiske kompositioner indeholdende disse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment